Zoetis Inc.
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$33.00B
Cash Runway
12.9 mo
Lead Asset
—
Next Catalyst
—
Go deeper on Zoetis Inc. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on ZTS — live, with citations.
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
12.9 months
D/E 3.69 · 0% dilution
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
3 buys · 2 sells (180d)
Key Financialsas of March 31, 2026
Cash
$1.94B
Quarterly Burn
$768.0M
Revenue
$2.26B
Free Cash Flow
$291.0M
Total Liabilities
$11.92B
Shareholders Equity
$3.23B
Current Ratio
3.15
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Commercialization & Governance
Commercialization
- Launch Markets
- -
Governance
- Board Size
- 12
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1,605
Total value held
$50.71B
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 52,145,692 | $6.16B |
| blackrock, inc. | 35,584,312 | $4.21B |
| vanguard portfolio management llc | 23,967,400 | $2.83B |
| state street corp | 19,324,401 | $2.28B |
| state farm mutual automobile insurance co | 15,892,903 | $1.88B |
| morgan stanley | 14,145,735 | $1.67B |
| geode capital management, llc | 11,349,248 | $1.34B |
| wellington management group llp | 10,150,096 | $1.20B |
| janus henderson group plc | 7,403,494 | $875.1M |
| nordea investment management ab | 5,865,111 | $679.8M |
Showing top 10 of 1,605 institutional holders of Zoetis Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
Who is the CEO of Zoetis Inc.?
Ms. Kristin C. Peck is the chief executive officer of Zoetis Inc. (ZTS).
Where is Zoetis Inc. headquartered?
Zoetis Inc. (ZTS) is headquartered in Parsippany, NJ, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on Zoetis Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.